Samsung, a noted manufacturer of televisions and other electronic devices, entered the world of biotechnology with its new division, Samsung Biologics, in May. Wasting no time, that company has launched a $300 million joint venture with Biogen Idec Inc. to develop and manufacture biosimilars.